BIO-TECHNE Corp — Director's Dealing 2024

Aug 19, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIO-TECHNE Corp (TECH)
CIK: 0000842023
Period of Report: 2024-08-15

Reporting Person: McManus Matthew (President - DGS)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-08-15	Performance Restricted Stock Units	$	A	15818	Acquired		Common Stock (15818)	Direct
2024-08-15	Restricted Stock Units	$	A	7912	Acquired		Common Stock (7912)	Direct
2024-08-15	Stock Option (Right to Buy)	$74.91	A	21320	Acquired	2034-08-15	Common Stock (21320)	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Performance Restricted Stock Units	$		Common Stock (2888)	2888	Direct
Performance Stock Option (Right to Buy)	$68.54	2031-02-01	Common Stock (7951)	7951	Direct
Restricted Stock Units	$		Common Stock (13861)	13861	Direct
Stock Option (Right to Buy)	$68.54	2031-02-01	Common Stock (15902)	15902	Direct

Footnotes

F1: Each restricted stock unit represents a contingent right to receive one share of Bio-Techne common stock.

F2: Vests in full or in part on 8/15/2026 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F3: 4,620 restricted stock units vest on 2/1/2025 and 2/1/2027, and 4,621 restricted stock units vest on 2/1/2026.

F4: Options to purchase 3,976 shares vest on 2/1/2025 and 2/1/2027, and options to purchase 3,975 shares vest on 2/1/2026 and 2/1/2028.

F5: Vests in full or in part on 8/15/2027 if certain performance goals are achieved (or such later date as performance is certified by the Administrator).

F6: 2,637 restricted stock units vest on each of 8/15/2025 and 8/15/2026, and 2,638 restricted stock units vest on 8/15/2027.

F7: Options to purchase 5,330 shares vest on each of 8/15/2025, 8/15/2026, 8/15/2027 and 8/15/2028.